AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B

RTT News

by Super Admin 28 Views

Today's Daily Dose brings you news about the encouraging immune response triggered by AstraZeneca's Covid-19 vaccine candidate in older adults, the first combination regimen authorized for emergency use by FDA for COVID-19, Pfizer/BioNTech mulling to file for emergency use approval of their COVID-19 shot, and uniQure's gene therapy trial results in Hemophilia B patients.